CroíValve
Signal active
Organization
Contact Information
Overview
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
About
Industries
Medical Device
Founded
2016
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
CroíValve headquartered in Europe, operates in the Medical Device sector. The company focuses on Medical Device and has secured $928.9M in funding across 28 round(s). With a team of 1-10 employees, CroíValve is actively contributing to advancements in Medical Device. Their latest funding round, Series B - CroíValve, raised $16.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
9
Lead Investors
0
Total Funding Amount
$33.2M
Details
6
CroíValve has raised a total of $33.2M in funding over 6 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Seed | |||
| 2022 | Early Stage Venture | 9.2M | ||
| 2023 | Early Stage Venture | |||
| 2024 | Early Stage Venture | 16.0M |
Investors
CroíValve is funded by 47 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Broadview Ventures | - | FUNDING ROUND - Broadview Ventures | 16.0M |
| Furthr | - | FUNDING ROUND - Furthr | 16.0M |
| CroíValve | - | FUNDING ROUND - CroíValve | 16.0M |
| Irrus Investments | - | FUNDING ROUND - Irrus Investments | 16.0M |
Recent Activity
There is no recent news or activity for this profile.